Establishment profile
ULTRAGENYX PHARMACEUTICAL
170 MIDDLESEX TURNPIKE, BEDFORD, MA, 01730
Operated by Ultragenyx Pharmaceutical Inc
541713 — Research and Development in Nanotechnology
Summary
ULTRAGENYX PHARMACEUTICAL has accumulated 2 OSHA violations across 1 inspection over 3 years of recorded history, with $12,054 in total assessed penalties.
The establishment sits in the 65th percentile for violations within its industry-state peer group of 55 employers. The most recent enforcement activity was recorded 3 years ago.
Federal records were found in 1 of 16 sources. Sources without matching records returned empty for this establishment.
Agency coverage
ULTRAGENYX PHARMACEUTICAL appears in OSHA workplace safety record only. No matching records were found in WHD wage enforcement, MSHA mine safety, EPA environmental compliance, NLRB labor relations, OFLC visa and labor certification, FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, UVA Corporate Prosecution Registry, CPSC product recalls, or NHTSA vehicle recalls. Single-agency enforcement records typically indicate either a discrete incident-based inspection or a low-risk operational profile.
OSHA workplace safety
100% of inspections at this establishment produced violations,
Peer comparison
Above average violations in NAICS 5417 within MA. Peer group: 55 employers. This establishment has 2 OSHA violations; peer median is 1.
Safety self-report (OSHA 300A)
No self-reported injury rates filed with OSHA's Injury Tracking Application for ULTRAGENYX PHARMACEUTICAL. Verify directly with OSHA Injury Tracking Application →
Industry benchmark
BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.
Inspection breakdown
Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.
OSHA severe injury reports
No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for ULTRAGENYX PHARMACEUTICAL. Verify directly with Occupational Safety and Health Administration →
Activity timeline
No federal enforcement activity has been recorded against this establishment in 3+ years. Most recent activity: 3 years ago. Data on this page is refreshed weekly.
Wage & Hour Division (WHD)
No WHD wage, overtime, or child-labor enforcement cases on file for ULTRAGENYX PHARMACEUTICAL. Verify directly with Wage and Hour Division →
Mine safety (MSHA)
No MSHA mine safety violations on file for ULTRAGENYX PHARMACEUTICAL. Verify directly with Mine Safety and Health Administration →
Labor relations (NLRB)
No NLRB unfair labor practice charges or union representation cases on file for ULTRAGENYX PHARMACEUTICAL. Verify directly with National Labor Relations Board →
Visa & labor certification (OFLC)
No H-1B, H-2A, or H-2B labor condition applications on file for ULTRAGENYX PHARMACEUTICAL. Verify directly with Office of Foreign Labor Certification →
Environmental compliance (EPA)
No EPA inspections or formal enforcement actions on file for ULTRAGENYX PHARMACEUTICAL. Verify directly with Environmental Protection Agency →
Federal criminal prosecution record
No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for ULTRAGENYX PHARMACEUTICAL. Verify directly with UVA Corporate Prosecution Registry →
Inspection history
| Date | Trigger | Violations | Serious | Penalty | |
|---|---|---|---|---|---|
| 2023-01-19 | Referral | 2 | — | $12,054 |
Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.
In the news
Part of a larger organization
ULTRAGENYX PHARMACEUTICAL is one of 1 establishments rolled up under the parent organization Ultragenyx Pharmaceutical Inc.
Federal enforcement records on this page represent activity at this specific establishment only. The full enforcement footprint of Ultragenyx Pharmaceutical Inc across all 1 of its tracked locations is viewable on the parent profile.
Other employers in this industry and state
Other employers in research and development in nanotechnology within MA, ordered by federal enforcement volume:
- LUMICKS USA, INC.WALTHAM — 1 federal enforcement record
- EIC LABORATORIES, INC.NORWOOD — 1 federal enforcement record
Related searches
- All Ultragenyx Pharmaceutical Inc locationsParent rollup
- Research and Development in NanotechnologyAll employers in this industry
- Employers in MAState-wide enforcement data
- Research and Development in MAIndustry × state cross-filter
Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.
Contact sales →About this data
This profile aggregates federal enforcement records on ULTRAGENYX PHARMACEUTICAL from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.
Establishments are matched across agencies using normalized employer name, state, and ZIP code. This establishment resolves to the parent rollup Ultragenyx Pharmaceutical Inc.
OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.
Frequently asked
- What is ULTRAGENYX PHARMACEUTICAL's OSHA violation history?
- ULTRAGENYX PHARMACEUTICAL has 1 OSHA inspection on record with 2 violations and $12,054 in total penalties.
- How does ULTRAGENYX PHARMACEUTICAL's safety record compare to its industry?
- ULTRAGENYX PHARMACEUTICAL operates in the research and development in nanotechnology industry. The industry average Total Recordable Incident Rate (TRIR) is 0.6.